Table 3.

Other clinical trials of rituximab currently underway.

  • Low Grade Lymphoma

    • In newly diagnosed patients: treatment as a single agent, and in combination with a variety of chemotherapy regimens

    • In relapsed disease: as repetitive courses or in combination with a variety of lymphokines and cytokines

    • In adjunct to BMT: either before, during, or after the procedure

  • Intermediate and High Grade Lymphoma

    • In newly diagnosed patients: in combination with standard chemotherapy regimens

    • In relapsed and refractory patients: in combination with a variety of chemotherapy regimens

    • As an adjunct to BMT, either before, during, or after the transplant procedure

 
  • Low Grade Lymphoma

    • In newly diagnosed patients: treatment as a single agent, and in combination with a variety of chemotherapy regimens

    • In relapsed disease: as repetitive courses or in combination with a variety of lymphokines and cytokines

    • In adjunct to BMT: either before, during, or after the procedure

  • Intermediate and High Grade Lymphoma

    • In newly diagnosed patients: in combination with standard chemotherapy regimens

    • In relapsed and refractory patients: in combination with a variety of chemotherapy regimens

    • As an adjunct to BMT, either before, during, or after the transplant procedure

 

or Create an Account

Close Modal
Close Modal